More than one thousand patients at Goshen Hospital in Indiana may have been exposed to HIV, hepatitis C and hepatitis B after an error in the sanitizing procedure for surgical equipment, according to a press release from Goshen Health.
Prior research had confirmed that biologic therapies can reactivate hepatitis B virus (HBVr) and hepatitis C in patients with psoriasis. Psoriasis patients with HBsAg-seropositive, HBeAg-seropositive, TNF- α inhibitor therapy, have a higher risk of HBVr and should be more closely monitored.
Conclusion NLR is correlated with SUVmax-mean values in ICC and resulted to be an easy available predictor of survival in patients submitted to treatment with 90Y-microspheres.
We recently read the article by Corma-G ómez A. et al. on which the authors described a higher probability of relapses with sofosbuvir/ledipasvir 8 weeks compared with 12 weeks of HCV (hepatitis C virus) among HIV (human immunodeficiency virus)/HCV coinfected patients.1 In this regard, coinfections of HIV/ HCV also with hepatitis B virus (HBV) is associated with high mortality and comorbidity too. The persistence of HBV DNA within the core cell in the absence of HBsAg and even after clearance of the infection has been described previously in immunosuppressed patients, where HBV screening and prophylaxis is recommended.
ConclusionOur study showed excellent efficacy with the safety profile of this drug combination in end-stage renal disease patients. However, larger prospective studies and multicenter randomized controlled trials are needed for further confirmation.
CONCLUSIONS An increased frequency of musculoskeletal manifestations, better than those reported in the medical literature, in patients infected with HBV and HCV was observed.
Conclusions. Hispanic patients with cirrhosis experience a survival advantage over many other racial groups despite adjustment for multiple covariates.
Publication date: Available online 26 November 2019Source: Journal of Clinical and Experimental HepatologyAuthor(s): Kapil Dhingra, Sandeep Ratra, Amit Tanwar, Munesh Kumar, Mukesh Jain, Gaurav Gupta, Shivi Nijhawan, Hemendra Bharadwaj, Manisha Nijhawn, Sandeep Nijhawan
Condition: Hepatitis C, Chronic Interventions: Diagnostic Test: HCV antibody and hepatitis B surface antigen (HBsAg) rapid diagnostic tests; Drug: DAAs Sponsor: Egyptian Liver Hospital Completed